NCT00952627View on ClinicalTrials.gov

Effects of Pycnogenol on Cardiac Fibrosis and Diastolic Dysfunction in Aged Hypertensive Subjects

PHASE2TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Cardiac FibrosisDiastolic Dysfunction
Interventions
DIETARY_SUPPLEMENT

Pycnogenol

50 mg tablet, 200 mg/day, 4 tablets/day

DIETARY_SUPPLEMENT

Placebo

Trial Locations (1)

85724

University of Arizona, Sarver Heart Center, Tucson

Sponsors

Collaborators (1)

Horphag Research
All Listed Sponsors
collaborator

Horphag Research

UNKNOWN

lead

University of Arizona

OTHER